Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: Esfandiar Lohrasbpour

DiscoveRx – cell-based assays

Posted on by

DiscoveRx is an innovative biotech company developing reagents, complete cell-based assay kits, profiling and screening services for life science and drug discovery markets.

DiscoveRx – cell-based assays

DiscoveRx

Continue reading →

Posted in Biotech Companies, Biotech Companies UK, Biotech Companies USA | Tagged ADP, BioMAP, BROMO scan, bromodomain, BROMOscan, calcium, cAMP assay, cell-based assay kit, cell-based assay kits, cell-based assays, cytokine, DiscoveRx, DiscoveRx - cell-based assays, EFC, enzyme fragment complementation, Esfandiar Lohrasbpour, fluorometric assay, GPCR, GPCR screening, HitHunter, InCELL Hunter, intracellular analyte, IP3, kinase, KINOME scan, KINOMEscan, Melissa Daniels, methyltranseferase, Microgenics, Morgan Stanley, nuclear hormone receptor, PathHunter, profiling, protease, Pyare Khanna, Richard Bastiani, Scott Halsted, screening, secreted protein, transcription factor, β-galactosidase, β-galactosidase enzyme fragment complementation

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress